Biotech Companies: Sarepta Stock Plunges On Gene Therapy News; Arena, Aerie Stock Diverge – Investor's Business Daily
Business News
- Biotech Companies: Sarepta Stock Plunges On Gene Therapy News; Arena, Aerie Stock Diverge Investor’s Business Daily
- Sarepta Therapeutics Comments on Erroneous Submission to US FDA Adverse Event Reporting System (FAERS) GlobeNewswire
- Sarepta’s stock price plummets after an ‘erroneous’ report – STAT STAT
- Sarepta Therapeutics (SRPT) Reports Q2 Loss, Tops Revenue Estimates Yahoo Finance
- Patient in Sarepta gene therapy trial develops serious illness; shares plunge CNA
- View full coverage on Google News
Source: Business News